Want to join the conversation?
Michael Rehaut of JPMorgan asks for an update on growth in North America. $WHR said 2Q16 reveue growth, ex-FX, was 4% and volume growth was 5%. The company is pleased with the market share progress and revenue growth. $WHR aims to grow at or above market in 2016 and expects a similar guidance for growth in 2017 and 2018.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.